Cefotaxime CAS:63527-52-6
Cefotaxime is prescribed by healthcare providers to treat bacterial infections such as respiratory tract infections, urinary tract infections, skin and soft tissue infections, sepsis, meningitis, and intra-abdominal infections. Before using cefotaxime, it is essential to consult a healthcare professional for proper diagnosis and dosage recommendation based on the specific infection being treated. The medication is usually administered through injection into a muscle or vein under medical supervision. It is crucial to complete the full course of cefotaxime as prescribed by the healthcare provider, even if symptoms improve before completion. Skipping doses or stopping the medication prematurely can lead to antibiotic resistance and may result in the infection not being fully treated. Common side effects of cefotaxime may include diarrhea, nausea, vomiting, or allergic reactions. If any severe side effects occur, such as difficulty breathing or swelling of the face, immediate medical attention should be sought. Overall, cefotaxime is an effective antibiotic when used correctly under medical guidance for the treatment of bacterial infections.
Composition | C16H17N5O7S2 |
Assay | 99% |
Appearance | white powder |
CAS No. | 63527-52-6 |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |